Publications by authors named "N Ruggli"

Wesselsbron virus (WSLV) is a zoonotic, mosquito-borne orthoflavivirus endemic to sub-Saharan Africa, causing abortions and stillbirths in small ruminants. The life cycle of WSLV involves Aedes mosquitoes and various wildlife and domestic animals. Seminal studies in the 1950s have shown the zoonotic potential of WSLV, notably in accidental infections of laboratory workers exposed to infected material.

View Article and Find Full Text PDF

African swine fever virus (ASFV) is the etiological agent of African swine fever, a highly contagious hemorrhagic disease affecting both wild boars and domestic pigs with lethality rates up to 100%. Until now, the most effective measure to prevent an outbreak of ASFV was early detection. In this situation, whole genome sequencing (WGS) allows the gathering of detailed information about the identity and epidemiology of the virus.

View Article and Find Full Text PDF

African swine fever virus (ASFV) has been spreading through Europe, Asia, and the Caribbean after its introduction in Georgia in 2007 and, due to its particularly high mortality rate, poses a continuous threat to the pig industry. The golden standard to trace back the ASFV is whole genome sequencing, but it is a cost and time-intensive methodology. A more efficient way of tracing the virus is to amplify only specific genomic regions relevant for genotyping.

View Article and Find Full Text PDF
Article Synopsis
  • - Japanese encephalitis virus (JEV) is primarily spread by mosquitoes and can lead to severe illness in humans, with the potential for direct transmission observed in pigs, raising concerns about outbreaks in unvaccinated pig populations.
  • - Experiments involving JEV passaging in pigs revealed increased viral replication and immune responses, but did not lead to enhanced direct transmission between pigs.
  • - Genetic analysis during the experiments identified mutations that may confer advantages to the virus in pigs, highlighting the evolution of viral quasispecies without improving transmission efficiency.
View Article and Find Full Text PDF

Live-attenuated influenza vaccines (LAIV) offer advantages over the commonly used inactivated split influenza vaccines. However, finding the optimal balance between sufficient attenuation and immunogenicity has remained a challenge. We recently developed an alternative LAIV based on the 2009 pandemic H1N1 virus with a truncated NS1 protein and lacking PA-X protein expression (NS1(1-126)-ΔPAX).

View Article and Find Full Text PDF